NCT04627207View on ClinicalTrials.gov

A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of CKD-333 and D085 in Healthy Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

November 30, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

April 30, 2021

Conditions
Cardiovascular Diseases
Interventions
DRUG

CKD-330 1 Tab. and D085 1 Tab.

Other names: Reference

DRUG

CKD-333 1 Tab

Other names: Test

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT04627207 - A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of CKD-333 and D085 in Healthy Volunteers | Biotech Hunter | Biotech Hunter